N/A
Completed N=20
Patient-Derived Organoids for Rectal Cancer
Rectum Cancer
Source: ClinicalTrials.gov NCT04371198 ↗
Enrolled (actual)
20
Serious AEs
—
Results posted
Aug 2023
Primary outcomePrimary: Number of Participants With Biopsies That Form Spherical Organoids — 14 Participants
Summary
The purpose of this study is to determine the feasibility of establishing patient-derived organoids from pre-treatment rectal adenocarcinoma biopsies.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Biopsies That Form Spherical Organoids |
14 | — |
Eligibility Criteria
Inclusion
- Age ≥18 years old.
- Able to provide informed consent.
- Undergoing proctoscopy.
Exclusion
- Patient not planned to receive neoadjuvant radiotherapy
Data sourced from ClinicalTrials.gov (NCT04371198). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.